LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 1 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 1. - Dataset (ID:20309)

 Full screen view
Filter results: >>>>
Cell Small Molecule Small Mol Concentration (uM) Time Point (hr) Total Cell Count Before Treatment Total Cell Count After Treatment Total Control Cell Count Relative Cell Count Normalized Growth Rate Inhibition Value Assay Plate Assay Well
MCF 10A-H2B-mCherry Trametinib
0.003
 54.49 770.25 4408 7555 0.5834 0.6982
MN20160304_L02
N12
MCF 10A-H2B-mCherry Trametinib
0.003
 56.71 770.25 4055 8001 0.5068 0.6354
MN20160304_L02
G13
MCF 10A-H2B-mCherry Trametinib
0.003
 56.71 770.25 4963 8001 0.6203 0.7362
MN20160304_L02
K07
MCF 10A-H2B-mCherry Trametinib
0.003
 56.71 770.25 4681 8001 0.5850 0.7064
MN20160304_L02
N12
MCF 10A-H2B-mCherry Trametinib
0.003
 58.94 770.25 4272 8444 0.5059 0.6420
MN20160304_L02
G13
MCF 10A-H2B-mCherry Trametinib
0.003
 58.94 770.25 5313 8444 0.6292 0.7490
MN20160304_L02
K07
MCF 10A-H2B-mCherry Trametinib
0.003
 58.94 770.25 4916 8444 0.5822 0.7101
MN20160304_L02
N12
MCF 10A-H2B-mCherry Trametinib
0.003
 61.16 770.25 4494 8892 0.5054 0.6484
MN20160304_L02
G13
MCF 10A-H2B-mCherry Trametinib
0.003
 61.16 770.25 5476 8892 0.6158 0.7433
MN20160304_L02
K07
MCF 10A-H2B-mCherry Trametinib
0.003
 61.16 770.25 5222 8892 0.5873 0.7200
MN20160304_L02
N12
MCF 10A-H2B-mCherry Trametinib
0.003
 63.39 770.25 4661 9326 0.4998 0.6493
MN20160304_L02
G13
MCF 10A-H2B-mCherry Trametinib
0.003
 63.39 770.25 5753 9326 0.6169 0.7487
MN20160304_L02
K07
MCF 10A-H2B-mCherry Trametinib
0.003
 63.39 770.25 5303 9326 0.5686 0.7096
MN20160304_L02
N12
MCF 10A-H2B-mCherry Trametinib
0.003
 65.61 770.25 4934 9736 0.5068 0.6610
MN20160304_L02
G13
MCF 10A-H2B-mCherry Trametinib
0.003
 65.61 770.25 5916 9736 0.6076 0.7455
MN20160304_L02
K07
MCF 10A-H2B-mCherry Trametinib
0.003
 65.61 770.25 5577 9736 0.5728 0.7176
MN20160304_L02
N12
MCF 10A-H2B-mCherry Trametinib
0.003
 67.83 770.25 5159 10078 0.5119 0.6697
MN20160304_L02
G13
MCF 10A-H2B-mCherry Trametinib
0.003
 67.83 770.25 6225 10078 0.6177 0.7564
MN20160304_L02
K07
MCF 10A-H2B-mCherry Trametinib
0.003
 67.83 770.25 5736 10078 0.5691 0.7181
MN20160304_L02
N12
MCF 10A-H2B-mCherry Trametinib
0.003
 70.05 770.25 5428 10413 0.5212 0.6816
MN20160304_L02
G13
MCF 10A-H2B-mCherry Trametinib
0.003
 70.05 770.25 6520 10413 0.6261 0.7656
MN20160304_L02
K07
MCF 10A-H2B-mCherry Trametinib
0.003
 70.05 770.25 5965 10413 0.5728 0.7243
MN20160304_L02
N12
MCF 10A-H2B-mCherry Trametinib
0.003
 72.27 770.25 5693 10730 0.5305 0.6927
MN20160304_L02
G13
MCF 10A-H2B-mCherry Trametinib
0.003
 72.27 770.25 6776 10730 0.6315 0.7721
MN20160304_L02
K07
MCF 10A-H2B-mCherry Trametinib
0.003
 72.27 770.25 6245 10730 0.5820 0.7345
MN20160304_L02
N12